Kaya Holdings Inc. (KAYS): Correct

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Re: Dbrown13 post# 6641

Thursday, 03/24/2016 6:54:24 PM

Thursday, March 24, 2016 6:54:24 PM

Correct

Full disclosure : Former executive consultant to KAYS and long shareholder

Keep Last Read

Replies (1) Next 10 Prev Next

Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 02/15/2024 09:38:31 PM
Investor Ideas Potcasts: Interview with Kaya Holdings (OTCQB: KAYS) on the Sacred Mushroom Center - Pioneers with Psilocybin and Advocates for Mental Health • InvestorsHub NewsWire • 11/28/2023 12:00:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 10:25:51 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 01:30:19 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/23/2023 08:15:17 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2023 11:48:09 AM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 08:15:57 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 12:44:25 PM
Kaya Holdings, Inc.'s V.P. Bryan Arnold Among First Ten (10) State Licensed Psilocybin Facilitators in U.S.A. • InvestorsHub NewsWire • 05/24/2023 01:48:14 PM

InvestorsHub NewsWire

FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM

Only $200 per official company press release!